FRONTEO Inc. (Headquarters: Minato-ku, Tokyo, President: Masahiro Morimoto, hereinafter FRONTEO) has announced the paper search AI "Amanogawa Ver. 1.3".

 

　"Amanogawa" uses artificial intelligence "Concept Encoder" and PubMed.^*This is a system that detects and analyzes the articles you want to search from the articles published in, not only from the keywords entered by the searcher, but also from the contents of hypotheses and abstracts (thesis abstracts).In this version, the following 3 functions have been added.

 

1. XNUMX.Screen layout customization
　"Amanogawa" consists of a main deck "Space Map" that displays the searched papers in a plot, and a cockpit part that displays the analysis results of the searched papers. Etc. can now be changed freely.
　In the cockpit part, you can check the contents of each cluster displayed on the "Space Map", "Terms Frequency", and the annual transition of each cluster, and you can grasp the trend of the contents of the paper at a glance. There are analysis screens such as "Chronological Chart", but these display sizes and positions can be freely changed according to the user's analysis style and needs, so that a researcher's original display screen can be constructed. became.

 

 

2.Word cloud display by cluster
　This is a new element added to the cockpit.The word cloud gives you a visual idea of ​​what keywords your search results are made up of. Amanogawa's word cloud eliminates general words such as articles and is created only with words that have research meanings such as molecular names, disease names, medical terms, etc., so users need it without the noise of general words. You will be able to check various information at a glance.

 

 

3. XNUMX.Filtering new documents
　This is a new function that displays only new documents on "Space Map".This makes it easier to check the status and contents of newly published documents.

 

 

　Through the development of AI systems, FRONTEO will continue to contribute to the promotion and efficiency of DX (digital transformation) in drug discovery research, as well as the improvement of medical quality and patient QOL.

 

* A database that allows you to search for articles in the field of biomedical science.Created by the National Center for Biological Sciences in the National Library of Medicine

 

■ About Amanogawa
URL: https://lifescience.fronteo.com/aidiscovery/amanogawa/
"Amanogawa (patent pending)" is a paper search AI system equipped with FRONTEO's original AI engine "Concept Encoder (registered trademark: concept encoder, reading: concept encoder)".When a researcher inputs a sentence such as a word or hypothesis of interest, "Concept Encoder" instantly detects the article related to the input content from the large number of articles published in PubMed.
Since the search results are plotted in a map according to the similarity between the articles, you can check the relevance at a glance, and drag the article information detected on the map to narrow down the search, which is a visual that has never been seen before. You can search for articles.In addition, you can sort the search results in order of relevance and list their abstracts, greatly streamlining your article search.This makes it possible to discover events and new drug targets from a perspective that is difficult for humans to notice.

■ About Concept Encoder
URL:https://lifescience.fronteo.com/technology/conceptencoder/
"Concept Encoder" is a natural language analysis AI (artificial intelligence) developed by FRONTEO specially in the life science field.It was developed in 2018 with the aim of effectively analyzing and utilizing medical data containing a large amount of free-form text data based on evidence. Concept Encoder can be co-analyzed with data other than text, and we are conducting research on co-analysis with numerical data such as gene expression information, vitals, and various test values ​​accumulated in the life science field.Patent registration number: Patent No. 6346367

■ About FRONTEO　URL:https://www.fronteo.com/
FRONTEO uses the in-house developed AI engine "KIBIT" and "concept encoder" specializing in natural language processing to extract meaningful and important information from a huge amount of text data to support corporate business. A data analysis company. Since its establishment in August 2003, it has been expanding globally to Japan, the United States, South Korea, and Taiwan, focusing on legal tech businesses such as "e-discovery (electronic discovery)" and "digital forensic investigation" that support international litigation of companies. Has been deployed.Based on the AI ​​technology cultivated in the legal tech business, we expanded the business field to the life science field, business intelligence field, and economic security from 8, and by using AI to "turn text data into knowledge" , Drug discovery support, dementia diagnosis support, financial / human resources / sales support, etc., contributing to solving various corporate issues. Listed on TSE Mothers on June 2014, 2007. January 6 Obtained a first-class medical device manufacturing and sales license (permit number: 26B2021X1).The capital is 13 thousand yen (as of March 1, 10350).

* FRONTEO, KIBIT, conceptencoder, and Amanogawa are registered trademarks of FRONTEO in Japan.